Chinese researchers identify biomarker for early detection of AD
Chinese researchers have identified a neuroimaging biomarker that can facilitate the early detection of Alzheimer's disease (AD).
AD is a chronic neurodegenerative disease characterized by progressive dementia. Neuroimaging techniques such as magnetic resonance imaging (MRI) can help diagnose AD. Accurate data-driven methods that can classify and characterize the neural features of AD would be powerful clinical tools.
Researchers from the Institute of Automation of the Chinese Academy of Sciences and other collaborators found that hippocampal radiomic features can be a promising personalized biomarker for AD.
In their search for suitable biomarkers, researchers proposed a novel hippocampal radiomic biomarker derived from structural MRI and systematically validated its reliability using neuroimaging data from over 1,900 individuals, including more than 700 located at six sites in China and around 1,200 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset.
The study showed that hippocampal radiomic features are related to the clinical features and changes in cognition ability. Long-term follow-up data in some hospitals demonstrated that the markers could be used to track the progression of the disease in high-risk subjects.
The research was published in the journal Science Bulletin.
Liu Yong, one of the researchers, said the research represents a large, interdisciplinary and interinstitutional effort between clinicians and researchers to develop and validate an AD neuroimaging biomarker.
The methodology can be extended to the study of other mental diseases. It has important clinical implications as the biomarker is promising for the early clinical diagnosis or prognostic follow-up in AD, Liu said.
Liu's team has dedicated itself to neuroimaging studies of AD that could provide relevant information to clinical practice.
The team is now focusing on further verification work among people with high risks of AD in more clinical centers, Liu added.
2026-10-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
US Imposes Heavy Duties on Chinese L-Lysine with Combined Rates up to 188%
-
Roche Phase III failure is out? Biogen/Eisai and Eli Lilly seize the AD opportunity
-
An Insight Into The Alzheimer's Breakthrough New Drug
-
BASF Raises European NPG and HDO Prices by Up to €300/Tonne as Costs Climb
-
The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share
-
EU Eyes Rare Trade Tool as PET, Epoxy Resin and Glass Fibre Face Import Curbs
-
Chemours Sells Its Former Titanium Dioxide Site in Taiwan: Turning a “White Powder” Factory into “Wind Power Real Estate” for $360 Million—Buying Not Cash, But Breathing Room
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
German Chemical Industry Posts Q2 Rebound but Capacity Utilization Remains at 73.2%
-
India Raises Cancer Drug Price Caps by 50%
Recommend Reading
-
Pfizer Warns Germany Over Drug-Pricing Policy
-
New York Targets Additives and GRAS Disclosure
-
Biologicals Move from Trial Plots to Real Distribution
-
China Methanol Futures Hit Limit-Up as More Than 60% of Middle East Capacity Remains Offline
-
Spain’s Data-Protection Confusion Hits Pesticide Competitiveness
-
Business Society’s PTA Market Outlook on September 10, 2026: Volatile
-
Business Society’s MTBE Market Outlook on August 13, 2026: Fluctuating Trend
-
Business Society’s Market Outlook for Acrylonitrile on September 10, 2026: Clearly Downward
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 13, 2026: Volatile
-
Bottom-fishing and restocking boost ABS to a rapid rise in mid-January